If you had hesitated over China Literature in October 2025 because the user base was shrinking and earnings were heavily tied to uneven film and TV releases, that caution would have spared a sharp outcome. Holding China Literature over the past year would have meant a 37.4% loss, including dividends. With recent results now showing revenue growth alongside a much thinner net margin, which early assumption about its dependence on hit IP and user trends most deserved closer attention?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
China Literature has already moved. See which of 189 high quality undervalued stocks still trade below our estimates.
The Two Stories China Literature Investors Had In Front Of Them
The shares cost HK$37.16 at the start of the period, and anyone looking at China Literature then was really choosing between two very different stories that both sounded plausible.
On the upbeat side, the bullish narrative put Fair Value at HK$48.35 and leaned on revenue growth of 11.7%. That view assumed profit margins could reach 21.1% and that a future P/E of 25.8x was reasonable.
The more cautious camp set Fair Value at HK$26.08. Their case rested on slower revenue growth of 4.5% and concerns that dependence on a shrinking user base and top IP could keep risk elevated, even if margins reached 18.5% on a 19.4x P/E assumption.
What The Results Put To The Test For China Literature
China Literature’s 2026 interim figures showed revenue of CNY 3,531.388m compared with CNY 3,190.584m in H1 2025, which leaned toward the bullish story on the top line. Profit told a different tale. Net income excluding extra items went from CNY 849.755m to CNY 135.376m and net margin moved from 26.6% to 3.8%, which clearly backed the cautious case on earnings risk.
The main assumption under the spotlight was that richer IP monetisation would translate into much fatter margins. When you test a similar claim elsewhere, track revenue alongside net margin and see whether higher IP income actually shows up in sustained profitability rather than just higher sales.
What The Fall In China Literature’s Share Price Now Asks You To Believe
China Literature trades at HK$22.3 today, and the selected Narrative places its Fair Value above that level based on expectations around IP focused earnings power rather than the legacy reading business.
That view leans on AI driven short dramas, games and overseas translation. For the fall to be an opportunity rather than a warning, a buyer would need confidence that newer IP operations can offset weaker online reading traffic and support healthier profitability.
"Management’s decision to tilt traffic toward visual formats, even as online reading MAUs and MPUs soften, indicates an intentional shift of user attention that can deepen monetization of short dramas, AI-animated content and related IP merchandise, and may support a mix shift toward higher IP operations margins."
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all
Find Your Own Contrarian Opportunity
This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.
- Company 1 - 25% below our estimate - expands its maintenance footprint by hiring more salespeople for recurring service contracts.
- Company 2 - 32% below our estimate - relies on long life gold reserves while managing higher operating costs and political risk.
- Company 3 - 33% below our estimate - introduces new nutrition products into additional export channels after saturating domestic distribution.
Three companies from the same screener. Open every one of the 203 solid balance sheet companies →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com